Joseph J. Schulz
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 7
- Colorectal Cancer Treatments and Studies 6
- Cancer Treatment and Pharmacology 3
- Pancreatic and Hepatic Oncology Research 1
-
- Cancer therapeutics and mechanisms 3
- Co-authors
- B. Nelson (1 shared paper)Fairooz F. Kabbinavar (1 shared paper)Michael McCleod (1 shared paper)William Novotny (1 shared paper)R. Mass (1 shared paper)Taral Patel (1 shared paper)J. Randolph Hecht (1 shared paper)John Hamm (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Chemotherapy and Pharmacology (2 papers)European Journal of Cancer (1 paper)American Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Joseph J. Schulz
8 papers receiving 1.5k citations
Joseph J. Schulz's Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 1.1k
- Hepatology 287
- Pulmonary and Respiratory Medicine 320
- Cancer Research 109
- Pathology and Forensic Medicine 110
Countries citing papers authored by Joseph J. Schulz
This map shows the geographic impact of Joseph J. Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph J. Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph J. Schulz more than expected).
Fields of papers citing papers by Joseph J. Schulz
This network shows the impact of papers produced by Joseph J. Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph J. Schulz. The network helps show where Joseph J. Schulz may publish in the future.
Co-authors
The 25 scholars most cited alongside Joseph J. Schulz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial Hit paper breakdown → | 2005 | 743 |
| 2 | Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study Hit paper breakdown → | 2007 | 682 |
| 3 | 2002 | 75 | |
| 4 | 2002 | 57 | |
| 5 | 1994 | 34 | |
| 6 | 2004 | 9 | |
| 7 | 2005 | 5 | |
| 8 | 1994 | 4 |
About Joseph J. Schulz
Joseph J. Schulz is a scholar working on Oncology, Molecular Biology, Toxicology, Surgery and Pharmacology, having authored 8 papers that have together received 1.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Cancer therapeutics and mechanisms (3 papers), Cancer Treatment and Pharmacology (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Genetic factors in colorectal cancer (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Gastric Cancer Management and Outcomes (1 paper). The work is most often cited by research in Oncology (1.1k citations), Hepatology (287 citations), Pulmonary and Respiratory Medicine (320 citations), Cancer Research (109 citations) and Pathology and Forensic Medicine (110 citations). Joseph J. Schulz has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include B. Nelson, Fairooz F. Kabbinavar, Michael McCleod, William Novotny, R. Mass, Taral Patel, J. Randolph Hecht, John Hamm, Vinod Ganju and Donald Richards. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, European Journal of Cancer and American Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.